A Proteomics Profiling Reveals the Neuroprotective Effects of Melatonin on Exogenous β‐amyloid‐42 Induced Mitochondrial Impairment, Intracellular β‐amyloid Accumulation and Tau Hyperphosphorylation in Human SH‐SY5Y Cells
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Jiraporn Panmanee, Matthew Phanchana, Phorutai Pearngam, Nopphon Petchyam, Kornkanok Promthep, Ponlawit Wisomka, Suchanoot Kutpruek, Supitcha Pannengpetch, Tanya Prasertporn, Sujira Mukda, Piyarat Govitrapong, Chutikorn Nopparat |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Spatial transcriptomics of cerebral amyloid angiopathy and amyloid‐β related angiitis
by: Marcel Seungsu Woo, et al.
Published: (2025)
by: Marcel Seungsu Woo, et al.
Published: (2025)
Neuroprotective effects of fosgonimeton and amyloid‐β‐targeting monoclonal antibodies against amyloid‐β toxicity in primary neuron culture
by: Sherif M Reda, et al.
Published: (2024)
by: Sherif M Reda, et al.
Published: (2024)
Correction to “Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production”
Published: (2024)
Published: (2024)
Spectroscopic investigations on metal coordination to amyloid‐β
by: Mingeun Kim, et al.
Published: (2025)
by: Mingeun Kim, et al.
Published: (2025)
No replicating evidence for anti‐amyloid‐β autoantibodies in cerebral amyloid angiopathy‐related inflammation
by: Emma van den Berg, et al.
Published: (2024)
by: Emma van den Berg, et al.
Published: (2024)
Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
by: Kazuki Yamada, et al.
Published: (2026)
by: Kazuki Yamada, et al.
Published: (2026)
Magnetic resonance imaging‐negative cerebral amyloid angiopathy: cerebrospinal fluid amyloid‐β42 over amyloid positron emission tomography
by: Jung‐Min Pyun, et al.
Published: (2024)
by: Jung‐Min Pyun, et al.
Published: (2024)
Microglial activation impacts amyloid‐β effects on reactive astrogliosis
by: João Pedro Ferrari‐Souza, et al.
Published: (2024)
by: João Pedro Ferrari‐Souza, et al.
Published: (2024)
The interactome of soluble amyloid‐β across the Alzheimer's disease continuum
by: Dietmar Rudolf Thal, et al.
Published: (2025)
by: Dietmar Rudolf Thal, et al.
Published: (2025)
Neuroinflammation potentiates the effect of amyloid‐β on longitudinal tau changes
by: Nesrine Rahmouni, et al.
Published: (2024)
by: Nesrine Rahmouni, et al.
Published: (2024)
Occipital amyloid‐β burden and clinical correlates in Lewy body disease
by: Hillary Vossler, et al.
Published: (2024)
by: Hillary Vossler, et al.
Published: (2024)
Plasma insulin is an early biomarker of amyloid‐β pathology in Alzheimer’s disease
by: Yuhan Chen, et al.
Published: (2024)
by: Yuhan Chen, et al.
Published: (2024)
Pyroglutamylation modulates electronic properties and the conformational ensemble of the amyloid β‐peptide
by: Darcy S. Davidson, et al.
Published: (2024)
by: Darcy S. Davidson, et al.
Published: (2024)
Climate change exposure and the takeover market: A text‐based analysis
by: Pongsapak Chindasombatcharoen, et al.
Published: (2024)
by: Pongsapak Chindasombatcharoen, et al.
Published: (2024)
Impact of COVID‐19 on Mental Health: Post‐Traumatic Stress and Coping Strategies Among Thai University Students Using Ordinal Logistic Regression Analysis
by: Peeradech Thichanpiang, et al.
Published: (2025)
by: Peeradech Thichanpiang, et al.
Published: (2025)
Choroidal–ventricular system abnormalities are linked to amyloid‐ β aggregation in Alzheimer's disease
by: Seyyed Ali Hosseini, et al.
Published: (2026)
by: Seyyed Ali Hosseini, et al.
Published: (2026)
Glymphatic dysfunction and β‐amyloid deposition in patients with idiopathic normal pressure hydrocephalus
by: Hanlin Cai, et al.
Published: (2025)
by: Hanlin Cai, et al.
Published: (2025)
Physiological β‐amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
by: Yuan Cheng
Published: (2024)
by: Yuan Cheng
Published: (2024)
LNODE: latent dynamics reveal the shared spatiotemporal structure of amyloid-$β$ progression
by: Wen, Zheyu, et al.
Published: (2026)
by: Wen, Zheyu, et al.
Published: (2026)
Fosgonimeton attenuates amyloid‐β‐induced autophagic impairments in primary cortical neurons
by: Sherif M Reda, et al.
Published: (2024)
by: Sherif M Reda, et al.
Published: (2024)
Microglia‐derived Galectin‐9 drives amyloid‐β pathology in Alzheimer's disease
by: Guoxin Zhang, et al.
Published: (2024)
by: Guoxin Zhang, et al.
Published: (2024)
STING deletion protects against amyloid β–induced Alzheimer's disease pathogenesis
by: Jessica M. Thanos, et al.
Published: (2025)
by: Jessica M. Thanos, et al.
Published: (2025)
Relationships between hypometabolism and both β‐amyloid and tau PET in corticobasal syndrome
by: Alma Ghirelli, et al.
Published: (2025)
by: Alma Ghirelli, et al.
Published: (2025)
Late‐life hypertension acts together with amyloid‐β pathology to promote memory loss
by: Lucas Uglione Da Ros, et al.
Published: (2024)
by: Lucas Uglione Da Ros, et al.
Published: (2024)
Aging and brain free cholesterol concentration on amyloid‐β peptide accumulation in guinea pigs
by: K. Sandy Pang, et al.
Published: (2024)
by: K. Sandy Pang, et al.
Published: (2024)
Improved analytical performance of plasma amyloid β assay using immunoprecipitation‐mass spectrometry
by: Akihito Korenaga, et al.
Published: (2025)
by: Akihito Korenaga, et al.
Published: (2025)
Exploration of the potential energy surface for the conformational interconversion of the amyloid $β$ peptide at the fibril end
by: Oishi, Yasuhiro, et al.
Published: (2025)
by: Oishi, Yasuhiro, et al.
Published: (2025)
Polygenic scores for Alzheimer’s disease risk and resilience predict age at onset of amyloid‐β
by: Eleanor K. O’Brien, et al.
Published: (2024)
by: Eleanor K. O’Brien, et al.
Published: (2024)
Age-related episodic memory declineand the role of amyloid-β: a systematic review
by: Jandirlly Julianna Souto
Published: (2021)
by: Jandirlly Julianna Souto
Published: (2021)
Biophysical analysis of angiotensin II and amyloid‐β cross‐interaction in aggregation and membrane disruption
by: Mohsen Habibnia, et al.
Published: (2025)
by: Mohsen Habibnia, et al.
Published: (2025)
Salivary β‐amyloid index 42/40 as a predictor in the diagnosis of Alzheimer's disease
by: Gustavo A A Santos
Published: (2025)
by: Gustavo A A Santos
Published: (2025)
Astrocyte reactivity associates with tau phosphorylation and neurodegeneration before detectable amyloid‐β pathology
by: Pampa Saha, et al.
Published: (2024)
by: Pampa Saha, et al.
Published: (2024)
Kefir peptides enhance neuron viability in a in vitro model of β‐amyloid aggregation
by: Fernanda Araújo do Prado mascarenhas, et al.
Published: (2025)
by: Fernanda Araújo do Prado mascarenhas, et al.
Published: (2025)
Astrocyte reactivity associates with tau phosphorylation and neurodegeneration before detectable amyloid‐β pathology
by: Pampa Saha, et al.
Published: (2024)
by: Pampa Saha, et al.
Published: (2024)
The Role of Green Corporate Finance in Enhancing Firm Resilience to Climate Change
by: Nopparat Wongsinhirun, et al.
Published: (2026)
by: Nopparat Wongsinhirun, et al.
Published: (2026)
Multilayer structural‐functional connectome changes are associated with amyloid‐β and tau pathologies in Alzheimer’s Disease
by: Meichen Yu, et al.
Published: (2024)
by: Meichen Yu, et al.
Published: (2024)
Clusters of modifiable risk factors provide resilience to the cognitive effects of β‐amyloid pathology in aging
by: Mohini Bhade, et al.
Published: (2024)
by: Mohini Bhade, et al.
Published: (2024)
Associations of several common infections with amyloid‐β pathology in vivo: a population‐based study
by: Caterina Felici, et al.
Published: (2024)
by: Caterina Felici, et al.
Published: (2024)
Human microglia differentially respond to β‐amyloid, tau, and combined Alzheimer's disease pathologies in vivo
by: Morgan A. Coburn, et al.
Published: (2025)
by: Morgan A. Coburn, et al.
Published: (2025)
Cerebrospinal fluid NPTXR changes and relationships with β‐amyloid load and metabolism by PET in Alzheimer’s disease
by: Ming Ni, et al.
Published: (2025)
by: Ming Ni, et al.
Published: (2025)
Similar Items
-
Spatial transcriptomics of cerebral amyloid angiopathy and amyloid‐β related angiitis
by: Marcel Seungsu Woo, et al.
Published: (2025) -
Neuroprotective effects of fosgonimeton and amyloid‐β‐targeting monoclonal antibodies against amyloid‐β toxicity in primary neuron culture
by: Sherif M Reda, et al.
Published: (2024) -
Correction to “Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production”
Published: (2024) -
Spectroscopic investigations on metal coordination to amyloid‐β
by: Mingeun Kim, et al.
Published: (2025) -
No replicating evidence for anti‐amyloid‐β autoantibodies in cerebral amyloid angiopathy‐related inflammation
by: Emma van den Berg, et al.
Published: (2024)